Shelton, Conn.
Nanoviricides began construction in August of 2013 on a clinical scale cGMP production plant in Shelton, Conn. Designed by Id3A, the project includes renovation of an existing 18,000-sf facility to provide research labs, offices, and a cGMP pharmaceutical manufacturing suite with cleanrooms for the production of active pharmaceutical ingredients (APIs). The project manager and engineering consultant for the renovation is MPH Engineering. Completion is expected in early 2014.
Source
